GRISEOFULVIN

Course overview

GRISEOFULVIN IS FDA APPROVED FOR AND THE DRUG OF CHOICE IN TINEA CAPITIS. OTHER INDICATIONS INCLUDE ONYCHOMYCOSIS AS WELL AS SUPERFICIAL FUNGAL INFECTIONS RESISTANT TO TOPICAL ANTIFUNGAL MEDICATIONS. THIS ACTIVITY WILL HIGHLIGHT THE MECHANISM OF ACTION, ADVERSE EVENT PROFILE, MONITORING, AND RELEVANT INTERACTIONS OF GRISEOFULVIN, PERTINENT FOR MEMBERS OF THE INTERPROFESSIONAL TEAM IN THE TREATMENT OF PATIENTS WITH THE CONDITIONS AS MENTIONED ABOVE USING GRISEOFULVIN.